STOCK TITAN

Enovix (ENVX) director Rodgers awarded 29,104 RSUs, holds over 22M shares via trusts

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Rodgers Thurman J reported acquisition or exercise transactions in this Form 4 filing.

Enovix Corp director and 10% owner Thurman J. Rodgers received a grant of 29,104 restricted stock units (RSUs) of Enovix common stock. The award was granted on June 11, 2026 at a price of $0.00 per share as compensation, not an open‑market purchase.

Each RSU represents a contingent right to receive one Enovix common share. Vesting will occur in four equal 25% installments on September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the date of Enovix’s 2027 annual stockholder meeting, subject to his continued service.

Following this grant, Rodgers directly holds 34,740 Enovix common shares, including the 29,104 shares underlying the RSUs. He also has indirect ownership through two trusts where he serves as trustee with voting and dispositive power, holding 1,120,114 and 20,875,314 Enovix common shares, respectively.

Positive

  • None.

Negative

  • None.

Insights

Rodgers received a time-vested RSU award, a routine equity grant.

The filing shows Thurman J. Rodgers, a director and 10% owner of Enovix Corp, was granted 29,104 RSUs at $0.00 per share. This is standard stock-based compensation rather than a market transaction, so it does not signal active buying or selling.

The RSUs vest in four 25% tranches between September 2026 and June 2027, contingent on continued service. After the grant, he holds 34,740 shares directly and large indirect positions of 1,120,114 and 20,875,314 shares through trusts where he has voting and dispositive power, indicating substantial ongoing exposure to Enovix equity.

Insider Rodgers Thurman J
Role null
Type Security Shares Price Value
Grant/Award Common Stock 29,104 $0.00 --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 34,740 shares (Direct, null); Common Stock — 20,875,314 shares (Indirect, Trust)
Footnotes (1)
  1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date. Includes 29,104 shares issuable upon the settlement of RSUs granted to the Reporting Person. The shares are held by the Rodgers Massey Revocable Living Trust dtd 4/4/11 for which the Reporting Person is a trustee and has voting and dispositive power over the shares. The shares are held by the Rodgers Family Freedom and Free Markets Charitable Trust for which the Reporting Person is a trustee and has voting and dispositive power over the shares.
RSU grant size 29,104 RSUs Granted June 11, 2026 at $0.00 per share
Direct holdings after grant 34,740 shares Enovix common stock directly held after RSU grant
Trust holdings (Revocable Living Trust) 1,120,114 shares Held by Rodgers Massey Revocable Living Trust; Rodgers is trustee
Trust holdings (Charitable Trust) 20,875,314 shares Held by Rodgers Family Freedom and Free Markets Charitable Trust
First vesting date September 11, 2026 25% of RSUs vest on this date
Final vesting trigger June 11, 2027 or 2027 meeting Remaining 25% vests on earlier of these dates
restricted stock units ("RSUs") financial
"Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Revocable Living Trust financial
"The shares are held by the Rodgers Massey Revocable Living Trust dtd 4/4/11 for which the Reporting Person is a trustee"
charitable trust financial
"The shares are held by the Rodgers Family Freedom and Free Markets Charitable Trust for which the Reporting Person is a trustee"
voting and dispositive power financial
"for which the Reporting Person is a trustee and has voting and dispositive power over the shares."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rodgers Thurman J

(Last)(First)(Middle)
C/O ENOVIX CORPORATION
3501 W. WARREN AVENUE

(Street)
FREMONT CALIFORNIA 94538

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Enovix Corp [ ENVX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/11/2026A29,104(1)A$034,740(2)D
Common Stock20,875,314ITrust(3)
Common Stock1,120,114ITrust(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects shares issuable on the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on each of September 11, 2026, December 11, 2026, March 11, 2027 and the earlier of (i) June 11, 2027; or (ii) the date of the Issuer's 2027 annual meeting of stockholders (or the date immediately preceding such date if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or not standing for re-election), subject to the Reporting Person's continuous service through each applicable vesting date.
2. Includes 29,104 shares issuable upon the settlement of RSUs granted to the Reporting Person.
3. The shares are held by the Rodgers Massey Revocable Living Trust dtd 4/4/11 for which the Reporting Person is a trustee and has voting and dispositive power over the shares.
4. The shares are held by the Rodgers Family Freedom and Free Markets Charitable Trust for which the Reporting Person is a trustee and has voting and dispositive power over the shares.
Remarks:
/s/ Arthi Chakravarthy, Attorney-in-Fact for Thurman J. Rodgers06/15/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Enovix (ENVX) director Thurman J. Rodgers receive in this Form 4 filing?

Thurman J. Rodgers received a grant of 29,104 restricted stock units (RSUs) of Enovix common stock at $0.00 per share. This is equity compensation, giving him the right to receive the same number of Enovix shares as the RSUs vest over time.

How do the Enovix (ENVX) RSUs granted to Thurman Rodgers vest?

The 29,104 Enovix RSUs vest in four equal 25% installments. Vesting dates are September 11, 2026, December 11, 2026, March 11, 2027, and the earlier of June 11, 2027 or the 2027 annual stockholder meeting date, subject to continuous service.

Is the Enovix (ENVX) Form 4 for Thurman Rodgers a stock purchase or sale?

No, it is not an open-market purchase or sale. The Form 4 reports a compensation-related grant of 29,104 RSUs at $0.00 per share. RSUs are promised shares that will be delivered as they vest, rather than shares bought or sold in the market.

How many Enovix (ENVX) shares does Thurman Rodgers hold directly after this RSU grant?

After the RSU grant, Thurman Rodgers directly holds 34,740 Enovix common shares. This amount includes the 29,104 shares that will be issued upon settlement of the RSUs granted to him, according to the Form 4 disclosure and related footnote.

What indirect Enovix (ENVX) holdings does Thurman Rodgers report through trusts?

Rodgers reports indirect Enovix holdings through two trusts. One trust holds 1,120,114 Enovix common shares, and another charitable trust holds 20,875,314 shares. He serves as trustee of both, with voting and dispositive power over the shares held by these trusts.

Why is Thurman J. Rodgers considered a 10% owner of Enovix (ENVX)?

He is treated as a 10% owner because, in addition to his direct holdings, he has large indirect positions through trusts holding 1,120,114 and 20,875,314 Enovix shares. As trustee, he has voting and dispositive power over these trust-held shares, contributing to his significant ownership stake.